Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite revision updated from v3.6.4 to v3.6.5. This change is a metadata update and does not modify the study details shown on the page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a small update to the page's revision metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s revision indicator updated from Revision: v3.6.2 to Revision: v3.6.3, signaling a software version update to the study details page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, signaling a small behind-the-scenes update to the page's documentation or formatting.SummaryDifference0.1%

- Check72 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. A revision note shows the page version updated to v3.6.0.SummaryDifference0.4%

- Check79 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a minor backend or template update rather than changes to the study data or content visible on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.